Is the Qiagen NV (QGEN) share over or underpriced?
Investors Observer gives Qiagen NV (QGEN) a strong valuation score of 63 based on its analysis. The proprietary rating system takes into account the underlying health of a company by analyzing its stock price, earnings and rate of growth. QGEN currently holds a better value than 63% of the shares based on these metrics. Long-term buy and hold investors should find the most relevant valuation ranking system when making investment decisions.
QGEN’s 12-month price-to-earnings (PE) ratio of 20.9 puts it above the all-time average of around 15. QGEN is a poor value at its current price, as investors pay more than they pay. it is worth relative to the company’s profits. . QGEN’s last 12-month earnings per share (EPS) of 2.55 does not justify what it is currently trading in the market. However, follower PE ratios do not take into account a company’s projected growth rate, resulting in some companies having high PE ratios due to high growth potentially attractive to investors, even though earnings current are weak. QGEN has a 12-month PE to Growth Futures (PEG) ratio of 1.85. The markets are overvaluing QGEN relative to its projected growth, as its PEG ratio is currently above fair market value of 1. The PEG of 2.54999995 comes from the fact that its forward price / earnings ratio is divided by its growth rate. PEG ratios are one of the most used valuation metrics due to the incorporation of more fundamental business metrics and the focus on the future of the business rather than its past.
QGEN’s valuation measures are weak at its current price due to an overvalued PEG ratio despite strong growth. QGEN’s PE and PEG are below the market average, resulting in a lower than average review score. Click here for the full Qiagen NV (QGEN) inventory report.